Inhibition of vascular endothelial growth factor signalling using cediranib (RECENTIN; AZD2171) enhances radiation response and causes substantial physiological changes in lung tumour xenografts.

Source:http://linkedlifedata.com/resource/pubmed/id/18819995

Download in:

View as

General Info

PMID
18819995